Awiqli is a new insulin injection that needs to be administered only once a week. Learn from a doctor about benefits, side ...

July 17 (Reuters) - Danish drugmaker Novo Nordisk said on Friday that India's drug regulator has approved its obesity drug ...

One injection a week instead of one every day. Danish drugmaker Novo Nordisk has launched Awiqli, or insulin icodec, in India-the world's first once-weekly bas ...

By Rishika Sadam July 9 (Reuters) - Danish drugmaker Novo Nordisk launched its weekly basal insulin injection, Awiqli, in ...

Indian pharma majors Sun Pharma, Dr Reddy's and Glenmark on Saturday announced the launch of their generic versions of ...

Lupin will gain semi-exclusive co-marketing rights for Zydus’ semaglutide injection in India under Semanext and Livarise, while Zydus retains its brands Semaglyn, Mashema and Alterme. Managing ...

Danish pharma major Novo Nordisk on Thursday launched in India its once-weekly basal insulin injection, ‘Awiqli’ indicated for treatment of diabetes in adults. The company is introducing Awiqli in two ...

Danish pharmaceutical company Novo Nordisk has launched Awiqli (insulin icodec) in India, making the country among the first to offer the world’s only ...

Novo Nordisk launched Awiqli, a once-weekly insulin, in India to treat type 1 and 2 diabetes. It aims to reduce injection ...

Launching its weekly insulin injectable 'Awiqli' in India, on Thursday, the Danish pharma major Novo Nordisk has brought some ...